Chronic caffeine consumption curbs rTMS-induced plasticity

Caffeine is a widely used psychostimulant. In the brain, caffeine acts as a competitive, non-selective adenosine receptor antagonist of A1 and A2A, both known to modulate long-term potentiation (LTP), the cellular basis of learning and memory. Repetitive transcranial magnetic stimulation (rTMS) is t...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in psychiatry Vol. 14; p. 1137681
Main Authors Vigne, Megan, Kweon, Jamie, Sharma, Prayushi, Greenberg, Benjamin D, Carpenter, Linda L, Brown, Joshua C
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 22.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Caffeine is a widely used psychostimulant. In the brain, caffeine acts as a competitive, non-selective adenosine receptor antagonist of A1 and A2A, both known to modulate long-term potentiation (LTP), the cellular basis of learning and memory. Repetitive transcranial magnetic stimulation (rTMS) is theorized to work through LTP induction and can modulate cortical excitability as measured by motor evoked potentials (MEPs). The acute effects of single caffeine doses diminish rTMS-induced corticomotor plasticity. However, plasticity in chronic daily caffeine users has not been examined. We conducted a secondary covariate analysis from two previously published plasticity-inducing pharmaco-rTMS studies combining 10 Hz rTMS and D-cycloserine (DCS) in twenty healthy subjects. In this hypothesis-generating pilot study, we observed enhanced MEP facilitation in non-caffeine users compared to caffeine users and placebo. These preliminary data highlight a need to directly test the effects of caffeine in prospective well-powered studies, because in theory, they suggest that chronic caffeine use could limit learning or plasticity, including rTMS effectiveness.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Neuroimaging, a section of the journal Frontiers in Psychiatry
Edited by: Chih-Wei Hsu, Kaohsiung Chang Gung Memorial Hospital, Taiwan
Reviewed by: Carmen Concerto, University of Catania, Italy; Tien-Wei Hsu, Kaohsiung Veterans General Hospital, Taiwan
Present address: Joshua C. Brown, Department of Psychiatry, McLean Hospital and Harvard Medical School, Boston, MA, United States
ISSN:1664-0640
1664-0640
DOI:10.3389/fpsyt.2023.1137681